ArticleFrontiers in immunology2022

Prognostic value of hematologic parameters in advanced non-small cell lung cancer patients receiving anti-PD-1 inhibitors.

Xinmin Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.